Ducks are all in a row!
-Wedbush upgraded price target of $77.
Analyst notes SHAK is 'even more attractive' post-COVID position and is still a "preeminent" growth story.
-Internationally, SHAK is seeing great demand in places like China, where countries have COVID under control.
-SHAK EPS is expected to grow over a 100% year over year.
-Technically price is above the 20 and 50 daily ma and on the verge of breaking the 200 daily ma.
-bullish volume spike
-finally breaking the downward sloping trend line.
- Price is clearly be consolidating between 50-55 range
-Price has also made a double bottom w/ Stoch divergence.